Credo Technology Group (NASDAQ:CRDO) reported quarterly earnings of $0.03 per share which met the analyst consensus estimate. The company reported quarterly sales of $46.50 million which beat the analyst consensus
Orchard Therapeutics (NASDAQ:ORTX) reported quarterly losses of $(0.04) per share. This is a 86.21 percent increase over losses of $(0.29) per share from the same period last year.